Bankinter SA (OTCMKTS:BKNIY – Get Free Report)’s share price gapped down prior to trading on Thursday. The stock had previously closed at $17.50, but opened at $16.27. Bankinter shares last traded at $16.2650, with a volume of 2,514 shares traded.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on the stock. Jefferies Financial Group raised shares of Bankinter from a “hold” rating to a “strong-buy” rating in a research note on Monday. Royal Bank Of Canada reiterated an “outperform” rating on shares of Bankinter in a research note on Friday, July 24th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy”.
View Our Latest Report on BKNIY
Bankinter Stock Down 7.1%
The company has a market cap of $14.62 billion, a PE ratio of 11.14 and a beta of -0.16. The stock has a 50-day moving average of $18.72 and a 200-day moving average of $17.68.
Bankinter (OTCMKTS:BKNIY – Get Free Report) last posted its earnings results on Thursday, October 22nd. The bank reported $0.38 EPS for the quarter, hitting the consensus estimate of $0.38. Bankinter had a return on equity of 18.20% and a net margin of 24.27%. Research analysts expect that Bankinter SA will post 1.52 EPS for the current year.
About Bankinter
Bankinter, SA is a Spanish financial institution headquartered in Madrid. The company provides banking and financial services to individuals, businesses, corporations and institutional clients, with activities spanning retail banking, corporate and investment banking, private banking, asset management and consumer finance.
Its products and services include current and savings accounts, loans and mortgages, credit cards, payment services, investment products, brokerage and wealth-management solutions.
Featured Stories
- Five stocks we like better than Bankinter
- Flywire’s Rapid Growth Faces a Q3 Test—Is Its Stock Already Too Expensive?
- Cologuard Is Working—So Why Isn’t Abbott Stock?
- Micron’s Taiwan Strike: A High-Stakes Fight Over AI Profits
- Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
Receive News & Ratings for Bankinter Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bankinter and related companies with MarketBeat.com's FREE daily email newsletter.
